Jennifer A. Rothman
Expertise in
3
conditions

Dr. Jennifer A. Rothman

Pediatrics
2301 Erwin Rd, 
Durham, NC 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
3
conditions
2301 Erwin Rd, 
Durham, NC 

Overview

I treat children with cancer and blood disorders, such as anemia and sickle cell disease. When families come in, there is understandably a huge amount of anxiety. I try to spend a lot of time with them and discuss what we know, what we need to find out, and how we plan to care for their children. My goal is to make it the least scary as possible for both the children and the parents/caregivers while providing the best care. Even in the setting of severe illness, interacting with children is uplifting and extremely rewarding. Children truly demonstrate the resilience of the human spirit. What I love most about my job is having relationships with children and seeing them grow; it is a wonderful experience.

Dr. Rothman is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Anemia, Immune Thrombocytopenic Purpura (ITP), Hydrops Fetalis, Fetal Edema, and Splenectomy.

Dr. Rothman is board certified in American Board Of Pediatrics, Pediatric Hematology-Oncology. She is actively involved in clinical research, co-authoring 46 peer reviewed articles and participating in 4 clinical trials. Dr. Rothman is currently accepting new patients.

Specialties

Pediatrics

Licenses

Pediatric Hematology-Oncology in NC

Board Certifications

American Board Of Pediatrics, Pediatric Hematology-Oncology

Fellowships

Pediatric Hematology and Oncology, Children's Hospital of Philadelphia (Pennsylvania)

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Duke Children's Health Center Hematology/Oncology Clinic
2301 Erwin Rd, Durham, NC 27710

Additional Areas of Focus

Dr. Rothman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II, Open-label, Non-controlled, Intra-patient Dose-escalation Study to Characterize the Pharmacokinetics After Oral Administration of Eltrombopag in Pediatric Patients With Refractory, Relapsed or Treatment Naive Severe Aplastic Anemia or Recurrent Aplastic Anemia
A Phase II, Open-label, Non-controlled, Intra-patient Dose-escalation Study to Characterize the Pharmacokinetics After Oral Administration of Eltrombopag in Pediatric Patients With Refractory, Relapsed or Treatment Naive Severe Aplastic Anemia or Recurrent Aplastic Anemia
Enrollment Status: Completed
Publish Date: August 10, 2026
Intervention Type: Drug
Study Drugs: Eltrombopag, Anti-Thymocyte Globulin, Cyclosporine
Study Phase: Phase 2
A Phase 2,Multicenter,Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab,With or Without Hydroxyurea/Hydroxycarbamide,in Sequential,Descending Age Groups of Pediatric Sickle Cell Disease Patients With Vaso-Occlusive Crisis
A Phase 2,Multicenter,Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab,With or Without Hydroxyurea/Hydroxycarbamide,in Sequential,Descending Age Groups of Pediatric Sickle Cell Disease Patients With Vaso-Occlusive Crisis
Enrollment Status: Completed
Publish Date: October 16, 2025
Intervention Type: Drug
Study Drug: Crizanlizumab
Study Phase: Phase 2
A Phase III Study of Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia in Children
A Phase III Study of Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia in Children
Enrollment Status: Completed
Publish Date: July 29, 2025
Intervention Type: Drug
Study Drugs: Eltrombopag, Steroids, IVIg, Rho(D) Immune Globulin
Study Phase: Phase 3
Pyruvate Kinase Deficiency (PKD) Natural History Study
Pyruvate Kinase Deficiency (PKD) Natural History Study
Enrollment Status: Completed
Publish Date: May 22, 2020
View 3 Less Clinical Trials

45 Total Publications

Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disorders.
Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disorders.
Journal: Blood advances
Published: February 05, 2026
Similar Doctors
Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Duke Health Integrated Practice Inc

40 Duke Medicine Cir, 
Durham, NC 
 (0.3 miles away)
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Priya Kishnani is a Pediatrics provider practicing medicine in Durham, North Carolina. Dr. Kishnani is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Pompe Disease, Glycogen Storage Disease Type 3, Hypophosphatasia (HPP), Glycogen Storage Disease Type 9, and Splenectomy. Dr. Kishnani is currently accepting new patients.

Expertise in
18
conditions
Dr. Henry S. Friedman
Neurosurgery | Hematology | Oncology
Expertise in
18
conditions
Dr. Henry S. Friedman
Neurosurgery | Hematology | Oncology
Referral may be required
Before you request

Duke Cancer Center Brain Tumor Clinic

20 Duke Medicine Cir, 
Durham, NC 
 (0.2 miles away)
919-684-5301
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Friedman is board certified in American Board Of Pediatrics, General Pediatrics and American Board Of Pediatrics, Pediatric Hematology-Oncology. Dr. Friedman is currently accepting new patients.

Expertise in
8
conditions
Expertise in
8
conditions
Referral may be required
101 Manning Dr, 
Chapel Hill, NC 
 (9.6 miles away)
919-966-4131
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joseph Muenzer is a Pediatrics provider practicing medicine in Chapel Hill, North Carolina. Dr. Muenzer is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), and Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A). Dr. Muenzer is currently accepting new patients.

Frequently Asked Questions about Dr. Jennifer A. Rothman

How do I make an appointment with Dr. Jennifer A. Rothman?

You can book an appointment with Dr. Jennifer A. Rothman by calling their office at 919-684-3401. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jennifer A. Rothman a top-rated expert for Splenectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jennifer A. Rothman is classified as an Elite expert for Splenectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jennifer A. Rothman specialize in?

While Dr. Jennifer A. Rothman is a Pediatrics, they have specific expertise in Splenectomy, Anemia, and Immune Thrombocytopenic Purpura (ITP). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Jennifer A. Rothman participate in research or clinical trials?

Yes. Dr. Jennifer A. Rothman has published 45 articles and abstracts on conditions like Splenectomy. You can view a list of Dr. Jennifer A. Rothman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jennifer A. Rothman accept my insurance?

Dr. Jennifer A. Rothman accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 919-684-3401 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rothman's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile